A New York Times investigation revealed multiple incidents where patients were prepped for organ procurement while still alive, raising concerns about the influence of donation organizations.

Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.

Shockwave Medical, now a part of Johnson & Johnson MedTech, has consistently been found safe for patients. However, many previous clinical trials excluded high-risk patients, making it important to track real-world outcomes as time goes on.

President Donald Trump has crystallized his No. 1 priority for artificial intelligence. Unshockingly, it’s “winning the AI race.” 

In a settled lawsuit, a surgeon and anesthesiologist admitted to playing the game and missing an alarm that warned them a 56-year-old patient had stopped breathing.

AI can improve the quality of remotely delivered care while simultaneously defending privacy and security for the telehealth patient. 

In fact, more than 55% of all PCI cases in 2022 were performed using radial access. Cardiologists are sure to be keeping a close eye on this trend as time goes on.

Targeting high-risk patients with single-pill combination therapies, also known as polypills, could change healthcare on a global scale, according new data published in the Journal of the American College of Cardiology.